'Smartening' anticancer therapeutic nanosystems using biomolecules

- Achieving highly selective cancer cell killing using chemotherapy has revealed more difficult than anticipated.
- Drug delivery systems could minimize off-target toxicity of chemotherapy, though they must overcome multiple physiological barriers to achieve this.
- Biomolecules can be used to transform bare nanoparticles into smart therapeutic nanosystems that sort out those barriers effectively.